Back to today’s briefing

Story perspectives

FDA Limits COVID Vaccine Access, Heightens Health Disparities

5/22/2025

25 2

Summary

Story summary

The FDA's revised COVID-19 vaccine guidelines now limit access for those over 65 and high-risk individuals, mandating rigorous trials for healthy adults under 65. This controversial change, driven by Health Secretary Robert F. Kennedy Jr., sparks fears of reduced vaccine availability and insurance coverage, threatening to deepen health disparities in vulnerable communities.

History

Historical Context

The FDA's revised COVID-19 vaccine guidelines echo past public health controversies, such as the 1976 swine flu vaccination campaign, which faced backlash over safety concerns. Historically, vaccine access has often been influenced by political decisions, risking disparities in healthcare. This change could exacerbate existing inequalities, reminiscent of earlier debates about equitable vaccine distribution during the COVID-19 pandemic.

1 of 2

Story summary

The FDA's revised COVID-19 vaccine guidelines now limit access for those over 65 and high-risk individuals, mandating rigorous trials for healthy adults under 65. This controversial change, driven by Health Secretary Robert F. Kennedy Jr., sparks fears of reduced vaccine availability and insurance coverage, threatening to deepen health disparities in vulnerable communities.

1 / 2